Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of FLNA will decline by -6.35% over the next 2 Weeks and hit $0.95 by Tuesday, August 4, 2026. In that time frame, FLNA's share price is expected to range between $0.88 and $1.01.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Aug 4, 2026 | 0.88 | 0.95 | 1.01 |
| Aug 3, 2026 | 0.90 | 0.96 | 1.02 |
| Jul 31, 2026 | 0.87 | 0.93 | 0.98 |
| Jul 30, 2026 | 0.88 | 0.94 | 1.00 |
| Jul 29, 2026 | 0.88 | 0.94 | 1.00 |
| Jul 28, 2026 | 0.91 | 0.98 | 1.04 |
| Jul 27, 2026 | 0.93 | 0.99 | 1.05 |
| Jul 24, 2026 | 0.90 | 0.96 | 1.02 |
| Jul 23, 2026 | 0.91 | 0.97 | 1.03 |
| Jul 22, 2026 | 0.91 | 0.97 | 1.03 |
FLNA shares fell -1.20% in Wednesday, July 22, 2026's trading session, dropping from a previous close of $1.01 to move at $1.00. The stock demonstrated notable intraday movement (see FLNA's key stats for a full breakdown), fluctuating between $0.98 and $1.02, a +4.08% trading range. While recent weeks have seen some volatility, FLNA has managed to secure a -15.43% drop over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 277.32K shares changing hands, 132.66K fewer than the previous session. This amounted to $276.73K in total market activity.
Will FLNA Continue Its Upward Trend?
According to analyst ratings and projections for FLNA, Filana Therapeutics, Inc. shares are anticipated to increase by +0.88%, potentially reaching $1.01 per share by August 4, 2026. Short-term technical indicators currently suggest a neutral sentiment for FLNA. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 11 positive trading days within the past 30 sessions. Based on the FLNA stock forecast, now is a good time to buy FLNA stock because its current trading price is +5.50% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on FLNA covering social and institutional perspectives.
FLNA Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into FLNA's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 22.81% to 33.29%) suggest the stock is experiencing strong bearish momentum. The 50-day RSI, at 39.42%, hints at potential weakness developing in the medium term. Additionally, the 100-day RSI, at 40.87%, maintains a neutral outlook for the long term. Insights into FLNA's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Filana Therapeutics Short-Term Forecasts
FLNA Forecast For Next 5 Days
Our algorithm anticipates Filana Therapeutics (FLNA) stock could hit $0.88 by Jul 29, 2026. This represents a -11.63% fall from today's price, following a - change over the past five days.
FLNA Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Filana Therapeutics, Inc. (FLNA) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $0.84, which would mean a -15.82% decrease from the current price of $1.00. Projections for this period range from a high of $1.11 to a low of $0.62.
FLNA Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Filana Therapeutics's price over the next three months point to a rise. FLNA stock is expected to peak at $12.28 on Jul 23, 2026 before potentially dipping to $3.02 on Oct 16, 2026. On average, FLNA is likely to trade around $6.30 in the coming 90 days.
Filana Therapeutics Stock Forecast 2025
Based on our predictive models, Filana Therapeutics (FLNA) is expected to trade between $0.73 and $12.28 throughout 2026. This would result in an average price of $4.37, potentially offering investors a +337.92% return from current levels.
Filana Therapeutics, Inc. Monthly Forecast 2026–2027
July 2026
According to our latest forecast models, Filana Therapeutics, Inc. (FLNA) is positioned to show a strong performance in July 2026. The price is predicted to move between $8.73 and $12.28, settling at an average of $10.96. This could translate to a +998.31% gain.
August 2026
Based on current market signals, Filana Therapeutics, Inc. is projected to trend august 2026. We forecast a trading range from $6.51 to $9.34, with a likely average price of $7.64. Investors could expect a potential return of +665.61%.
September 2026
Our predictive algorithms indicate Filana Therapeutics, Inc. stock may see a shift in September 2026. The expected range spans $4.16–$6.48, with an average target of $5.39. This represents a positive outlook and a possible gain of +440.13%.
October 2026
Analyzing established trends, Filana Therapeutics, Inc. looks set to move in October 2026. Projections place the stock between $2.70 and $4.18, averaging around $3.32. This suggests a +232.70% gain from current levels.
November 2026
Market indicators suggest Filana Therapeutics, Inc. could experience notable changes during November 2026. Prices could fluctuate within $1.66 to $2.55, with a midpoint forecast of $2.05. The stock might deliver a +105.43% gain.
December 2026
Forecasting for December 2026, models estimate that Filana Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.73 and $1.65, averaging $1.23. This signals a positive trajectory with potential returns around +23.26%.
January 2027
According to our latest forecast models, Filana Therapeutics, Inc. (FLNA) is positioned to show a strong performance in January 2027. The price is predicted to move between $0.51 and $0.88, settling at an average of $0.68. This could translate to a -31.86% loss.
February 2027
Based on current market signals, Filana Therapeutics, Inc. is projected to trend february 2027. We forecast a trading range from $0.27 to $0.52, with a likely average price of $0.40. Investors could expect a potential return of -59.92%.
March 2027
Our predictive algorithms indicate Filana Therapeutics, Inc. stock may see a shift in March 2027. The expected range spans $0.16–$0.28, with an average target of $0.22. This represents a cautious outlook and a possible loss of -77.95%.
April 2027
Analyzing established trends, Filana Therapeutics, Inc. looks set to move in April 2027. Projections place the stock between $0.08 and $0.18, averaging around $0.13. This suggests a -86.97% loss from current levels.
May 2027
Market indicators suggest Filana Therapeutics, Inc. could experience notable changes during May 2027. Prices could fluctuate within $0.03 to $0.10, with a midpoint forecast of $0.07. The stock might deliver a -92.99% loss.
June 2027
Forecasting for June 2027, models estimate that Filana Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.02 and $0.06, averaging $0.04. This signals a cautious trajectory with potential returns around -95.99%.
July 2027
According to our latest forecast models, Filana Therapeutics, Inc. (FLNA) is positioned to show a strong performance in July 2027. The price is predicted to move between $0.01 and $0.04, settling at an average of $0.03. This could translate to a -96.99% loss.
FLNA's history of dividends and stock splits also plays a role in long-term investor confidence.

